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Adenosine is an important modulator of neuronal survival and differentiation in the CNS. Our previous
work showed that nucleoside transporters (NTs) are present in cultures of chick retinal cells, but little
is known about the mechanisms regulating adenosine transport in these cultures. Our aim in the present
work was to study the participation of the adenosine metabolism as well as the ERK pathway on aden-
osine uptake in different types of retinal cultures (mixed and puriﬁed glial cultures). Kinetic analysis in
both cultures revealed that the uptake reached equilibrium after 30 min and presented two components.
Incubation of cultures with S-(p-nitrobenzyl)-6-thioinosine (NBTI) or dipyridamole, different inhibitors of
equilibrative nucleoside transporters (ENTs), produced a signiﬁcant and concentration-dependent uptake
reduction in both cultures. However, while dipyridamole presented similar maximal inhibitory effects in
both cultures (although in different concentrations), the inhibition by NBTI was smaller in glial cultures
than in mixed cultures, suggesting the presence of different transporters. Moreover, pre-incubation of
[3H]-adenosine with adenosine deaminase (ADA) or adenosine kinase (ADK) inhibition with iodotuberci-
din promoted signiﬁcant uptake inhibition in both cultures, indicating that the uptake is predominantly
for adenosine and not inosine, and that taken up adenosine is preferentially directed to the synthesis of
adenine nucleotides. In both cultures, the MEK inhibitors PD98059 or UO126, but not the inactive analog
U0124, induced a signiﬁcant and concentration-dependent uptake decrease. We have not observed any
change in adenosine metabolism induced by MEK inhibitors, suggesting that this pathway is mediating
a direct effect on NTs. Our results show the expression of different NTs in retinal cells in culture and that
the activity of these transporters can be regulated by the ERK pathway or metabolic enzymes such as ADK
which are then potential targets for regulation of Ado levels in normal or pathological conditions.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Adenosine mediates its effects via speciﬁc G-protein-coupled
receptors named A1, A2A, A2B and A3 [1,2]. Activation of A1 recep-
tors (A1Rs) has been shown to be neuroprotective during ischemia
and epilepsy [3,4], and together with synaptic modiﬁcations in-
duced by stress in hippocampus, a down regulation of these recep-
tors was reported [5]. Nevertheless, A1Rs could also exacerbate
neurotoxic effects induced by kainate in cultured cortical neurons
[6]. Adenosine intra and extracellular levels are regulated by bidi-
rectional NTs and enzymes related to purine metabolism. NTs are
classiﬁed as concentrative or equilibrative. Three subtypes of con-
centrative transporters promote nucleoside inﬂux in a sodium-
dependent manner [7]. On the other hand, there are four described
subtypes of equilibrative transporters, which promote sodium-
independent nucleoside transport according to the concentration
gradient [7], and ENT1 and ENT2 are the predominant isoformsvalho).
lsevier OA license.expressed in the CNS [8,9]. Concerning the enzymes, adenosine
kinase (ADK) and ADA are the main players in adenosine inactiva-
tion. Few studies have shown that ADK activity can be regulated by
different kinases. For example, some reports show the modulation
of ADK expression or activity in different cellular models by differ-
ent kinases and signaling molecules, such as calcineurin [10], ERK
1/2 activated by insulin [11] and nitric oxide [12]. To our knowl-
edge, few studies show measurements of ADK activity in retina
[13], but several studies reported the presence of adenosine, its
receptors and transporters in retinas from different species [13–
17]. In chicken retina, the presence of ENT1 was demonstrated
using [3H]-NBTI binding and shown to be present from embryonic
day 8 up to post-hatching animals [18]. This work also showed the
presence of [3H]-NBTI binding sites mostly in plexiform layers, in a
localization similar to that of A1Rs [18]. Co-localization of ENT1
and A1Rs was also observed in other CNS structures [19]. The pres-
ence of ENT1 was previously detected in chick retina mixed neuro-
nal/glial cultures [20] as well as in puriﬁed chick retina neuronal
cultures [16]. Some additional work has already demonstrated that
NTs are modulated by protein kinases such as PKC [21], PKA [22]
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take is modulated by CAMK II [24]. Here, we have investigated
the mechanisms involved in the regulation of adenosine uptake
in different types of chick retinal cultures. We found that the up-
take kinetic parameters or inhibition proﬁle by NT blockers differ
in mixed or glial cultures, but is similarly inhibited by ADK inhib-
itor or ERK pathway blockers.2. Materials and methods
2.1. Materials
FertilizedWhite Leghorn eggs were obtained from a local hatch-
ery and incubated at 38 C in a humidiﬁed atmosphere. L-Glutamine,
adenosine deaminase (ADA), NBTI, adenosine, 50-iodotubercidin,
1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadi-
ene monoethanolate (U0126), 2-(2-amino-3-methoxyphenyl)-4H-
1-benzopyran-4-one (PD98059), dipyridamole, penicillin G and
streptomycin sulfatewere obtained fromSigma/RBI Chem. Co. (Mis-
souri, USA). U0124 was obtained from Tocris Bioscience (Ellisville,
MO, USA). Minimum essential medium (MEM), heat-inactivated
fetal bovine serum (FBS) and trypsin were obtained from GIBCOFig. 1. Kinetic characterization of adenosine uptake in mixed (A and C) and glial cultu
(0.2 lCi/ml) plus different non-labeled adenosine concentrations for 15 min at 37 C or in
buffer, and lysed in water to determine intracellular radioactivity. Values represent mea
triplicate. The points without bars represent the results in which the deviation from the
data.(New York, USA). [2–3H]-Adenosine (22–28 Ci/mmol) was obtained
from GE Healthcare Life Sciences (Buckinghamshire, United
Kingdom). All other reagents were of analytical grade.2.2. Preparation of mixed cultures
Mixed cultures of chick retina cells were prepared as previously
described [25]. Brieﬂy, retinas from 8-day-old chick embryos (E8)
were dissected and digested with 0.2% trypsin, in calcium and
magnesium-free Hank’s solution (CMF), for 15 min at 37 C. Cells
were suspended in MEM supplemented with 3% heat-inactivated
fetal bovine serum, penicillin (100 U/ml), streptomycin (100 mg/
ml) and glutamine (2 mM), and seeded in tissue culture plastic
dishes in a density of 2  104 cells/mm2. Cultures were maintained
at 37 C in a humidiﬁed incubator with 95% air and 5% CO2. The
medium was changed after 1 day in culture (C1) and experiments
were performed at C3–C4.2.3. Preparation of Puriﬁed Muller glia cultures
Puriﬁed Muller glia chick retina cultures were prepared as pre-
viously described [26], with minor modiﬁcations. Cells wereres (B and C). (A and B) Cultures were washed and incubated with [3H]-adenosine
cubated with [3H]-adenosine (0.2 lCi/ml) for different periods of time (C), rinsed in
ns ± SEM and the results shown are from three separate experiments performed in
mean was smaller than the symbol size. (A and B, right): Eadie–Hofstee plot of the
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1.8  106 cells/ml. Cultures were maintained at 37 C in a humidi-
ﬁed incubator with 95% air and 5% CO2. The medium was changed
every 3 days and experiments were performed at C21.
2.4. [3H]-Adenosine uptake assays
All adenosine uptake assays were conducted at 37 C in HEPES-
buffered salt solution (HBSS) containing 140 mM NaCl, 5 mM KCl,
20 mM HEPES, 4 mM glucose, 1 mM MgCl2 and 2 mM CaCl2, pH
7.4. Before the experiments, the medium was removed and the
wells rinsed twice with HBSS solution. Cultured cells were pre-
incubated for 10 min in absence or presence of different drugs,
[3H]-adenosine (0.2 lCi/ml, 150 nM) was added and cultures fur-
ther incubated for 15 min. The dishes were then rinsed twice with
HBSS solution and lysed with water for determination of intracel-
lular radioactivity by liquid scintillation.
2.5. Identiﬁcation of intracellular radioactivity by thin layer
chromatography (TLC)
In order to analyze the intracellular radioactivity after [3H]-
adenosine uptake, cells were lysed with 5% TCA, removed from
the dishes, the material centrifuged at 20,627g for 15 min and
the supernatant mixed with standards, applied to TLC plates and
run in a mixture of butanol, ethyl acetate, methanol and ammo-
nium hydroxide (7:4:3:4) [27]. The spots detected under UV light
were scrapped off from the plates and the radioactivity determined
by liquid scintillation.
2.6. Statistical analysis
Data are presented as mean ± SEM from n experiments. Statisti-
cal signiﬁcance was assessed by one-way ANOVA followed by the
Bonferroni test, using GraphPad Prism 5 software. Values of
p < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Characterization of NTs involved in adenosine uptake by cultured
retinal cells
We have characterized the kinetic parameters involved in
adenosine uptake inmixed neuronal/glial and puriﬁed glial cultures
in order to deﬁne the time of incubation with [3H]-adenosine, as
well as the adenosine concentration to be used in subsequent
experiments. Adenosine transport in both cultures was concentra-
tion-dependent (Fig. 1A and B) and exhibited at least two uptakeFig. 2. Effects of NBTI and dipyridamole on [3H]-adenosine uptake in mixed and glial
concentrations of NBTI or dipyridamole for 10 min and subsequently incubated for 15 m
least three separate experiments performed in triplicate and error bars are not shown wcomponents, as demonstrated by Eadie–Hofstee plot, which was
curvilinear in both cultures (Fig. 1A and B, right panels). The Km val-
ues observed inmixed cultureswere 14.4 ± 2.4 and 130.9 ± 42.0 lM
and Vmax values 51.1 ± 6.5 and 258.6 ± 64.7 pmols/mg protein.
minute. In contrast, different values were obtained in glial cultures
(Kms of 30.4 ± 7.2 and 300.8 ± 29.7 lM and Vmaxs of 38.1 ± 7.6 and
263.8 ± 23.0 pmols/mg protein.minute). The time course of adeno-
sine uptake was linear for incubation times ranging from 0.5 to
15 min in both cultures and tended to equilibrium in mixed cul-
tures but not in glial cultures (Fig. 1C). All subsequent experiments
were performed using the incubation time of 15 min for both types
of culture.We have not observed any change on [3H]-adenosine up-
take when using sodium-free HBSS (data not shown), suggesting an
absence of sodium-dependent concentrative nucleoside transport-
ers in both cultures. In order to characterize the relative contribu-
tion of ENT1 and 2, we decided to use NBTI and dipyridamole,
two different inhibitors of ENTs. Our results demonstrated that
treatment with each inhibitor led to inhibition of [3H]-adenosine
uptake in both cultures in a concentration-dependent fashion
(Fig. 2A and B). Interestingly, the maximal inhibition with NBTI
was larger in mixed than in glial cultures (Fig. 2A) but the same
was not observed with dipyridamole (Fig. 2B), which presented a
very similar maximal inhibition but with very distinct concentra-
tions. In mixed cultures, dipyridamole and NBTI presented a very
similar inhibition proﬁle, a fact that was not observed in glial
cultures (compare Fig. 2A and B).
3.2. ADK is a main driving force for adenosine uptake in retinal
cultures
Pre-incubation of [3H]-adenosine with ADA (2 U/ml) for 45 min
before addition to cultures strongly reduced the uptake in both
mixed and glial cultures (Fig. 3A), demonstrating a low efﬁciency
of cells to take up inosine, the product of adenosine deamination.
In order to verify if ADK was an important driving force for aden-
osine uptake in retinal cultures, we used 50-iodotubercidin, a
known inhibitor of ADK. A signiﬁcant reduction of uptake was
observed in both cultures after treatment with this compound at
different concentrations (Fig. 3B).
3.3. Inhibition of adenosine uptake by MEK inhibitors
Few studies have shown that ERK is able tomodulate the expres-
sion and/or activity of neurotransmitter transporters, as for exam-
ple glutamate transporters [28], as well as dopamine transporters
[29]. PD98059 or UO126, two MEK inhibitors, produced concentra-
tion-dependent inhibitory effects on [3H]-adenosine uptake in both
mixed and glial cultures (Fig. 4A and B, respectively). We have alsocultures. (A and B) Cells were pre-incubated in absence or presence of different
in at 37 C after addition of [3H]-adenosine. The values are the mean ± SEM from at
here the SEM values were smaller than the size of the symbol.
Fig. 3. Effect of [3H]-adenosine pre-incubation with ADA and ADK inhibition on [3H]-adenosine uptake in mixed and glial cultures. (A) [3H]-adenosine (0.2 lCi/ml) was pre-
incubated with ADA (2 U/ml) for 45 min at 37 C and subsequently added to the cultures which were further incubated for 15 min at 37 C. (B) Cells were pre-incubated in
absence or presence of different ITU concentrations (100 or 300 nM) for 10 min and then subsequently incubated for 15 min at 37 C after addition of [3H]-adenosine. Values
are the mean ± SEM from at least three separate experiments performed in triplicate. ⁄⁄⁄p < 0.001 (compared to control).
Fig. 4. Effect of MEK inhibitors PD98059 or U0126 on [3H]-adenosine uptake and metabolism by cultured retinal cells. (A and B, mixed and glial cultures, respectively)
Cultures were washed and pre-incubated for 10 min with different concentrations of PD98059 or U0126 and subsequently incubated for 15 min at 37 C after addition of
[3H]-adenosine and cell lysis for determination of intracellular radioactivity. (C) Cultures were washed and pre-incubated in absence or presence of U0124 (10 lM) for 10 min
and subsequently incubated for 15 min at 37 C after addition of [3H]-adenosine. Cells were then lysed and the intracellular radioactivity determined. Values represent the
mean ± SEM from at least three separate experiments performed in triplicate. (D) Distribution of intracellular radioactivity after [3H]-adenosine uptake in control and
PD98059 (25 lM) or U0126 (10 lM)-treated mixed cultures. After incubation with [3H]-adenosine, intracellular radioactivity was extracted and the samples applied with
standards to TLC plates. The results are expressed in percent of total radioactivity and represent the mean ± SEM from three separate experiments.
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shown). Previous studies indicate that some kinase inhibitors could
have non-speciﬁc effects on NTs in a way independent of kinase
inhibition [30,31]. We then used U0124, an inactive analog of
U0126 which does not inhibit MEK activity, and found that this
compound produced no change on uptake in mixed cultures
(Fig. 4C). To verify whether the observed decrease on uptake pro-
moted by different MEK inhibitors was due to inhibition of adeno-
sine metabolism, we performed experiments measuring adenosine
metabolites using TLC. As can be observed in Fig. 4D, we have not
observed any detectable change in the metabolite proﬁle of mixed
cultures after treatment with PD98059 or UO126.4. Discussion
4.1. ENTs are the main mediators of [3H]-adenosine uptake in retinal
cultures
Adenosine markers such as different receptors and transporter
systems are known to be expressed in the retina in vivo and in cul-
tured retinal cells [16–18,24,32]. However, very little is known
about the characteristics of [3H]-adenosine uptake and the mecha-
nisms involved in the regulation of intracellular or extracellular
nucleoside levels. Our previous work has already demonstrated
that uptake sites labeled with [3H]-NBTI and detected using
A. dos Santos-Rodrigues et al. / Biochemical and Biophysical Research Communications 414 (2011) 175–180 179binding and auto-radiographic methods are present in developing
chicken retinas from E8 up to post-hatching animals [18]. At E8,
NBTI binding sites showed a diffuse distribution, but are localized
to the plexiform layers of more developed retinas, a similar local-
ization as that found for A1Rs [18]. This co-localization between
ENT1 and A1Rs was also observed in different brain structures
[19]. In the present study, we have shown that ENTs are the main
mediators of [3H]-adenosine uptake in mixed cultures, in a way
similar to what was found in cultured chick retinal neurons [16],
where [3H]-adenosine uptake was inhibited more than 80% by
NBTI. However, glial cultures showed a different proﬁle and a
maximum of 50% inhibition of uptake was observed with NBTI.
Interestingly, dipyridamole did promote a maximum of 80% inhibi-
tion in both cultures, although with different potencies. These re-
sults strongly indicate that mixed or glial cultures express uptake
sites with different pharmacological properties. One hypothesis is
that glial cells grown in puriﬁed cultures express ENT2 besides
ENT1 transporters with ENT2 being sensitive to dipyridamole but
not to NBTI, as shown in other studies [7,33].
4.2. Control of adenosine metabolism by different protein kinases
Adenosine uptake systems present in mixed or glial cultures are
more efﬁcient in taking up adenosine than inosine, since we had a
large decrease of uptake in both cultures when [3H]-adenosine was
pre-incubated with ADA. This result is in accordance with data
showing that ENT1 presents low afﬁnity for inosine (Km 170 lM
as compared to 40 lM for adenosine), while ENT2 has an afﬁnity
almost fourfold higher for inosine than ENT1 (Km 50 lM) [33,34].
Accordingly, the study by Zamzow et al. [35] indicates that inosine
is released through ENT2.
Besides NTs, ADK and ADA activities are also important in the
regulation of adenosine levels. Our previous work has already
demonstrated that, in mixed and puriﬁed neuronal cultures, most
of the taken up [3H]-adenosine is converted to adenine nucleotides
[16,24], as also observed in mouse primary cultured cortical astro-
cytes [36]. In puriﬁed glial cultures, similarly to what was observed
in other retinal cultures, we have observed an intense conversion
of taken up [3H]-adenosine to nucleotides (data not shown). These
data suggest that chick retinal cultures have a strong ADK activity.
On the other hand, some groups have already shown, using differ-
ent models [36,37], that most taken up adenosine is converted to
inosine/hypoxanthine, indicating a larger ADA activity with respect
to ADK. However, ADA activity does not seem to have a signiﬁcant
role in our cultures, because incubation with EHNA, an ADA inhib-
itor, did not induce any change in [3H]-adenosine uptake (data not
shown). On the other hand, we have observed a signiﬁcant reduc-
tion of [3H]-adenosine uptake in mixed and puriﬁed glial cultures
treated with 50-iodotubercidin, an ADK inhibitor.
4.3. Control of NTs by different protein kinases
NTs may have their activity regulated by activation/inhibition of
protein kinases, despite the cellular mechanisms involved still re-
main not understood. Different kinases were previously reported
to modulate adenosine uptake [21,22,24,38–41]. In this study,
PD98059 and U0126, two different MEK inhibitors, caused a strong
and signiﬁcant decrease of [3H]-adenosine uptake in both mixed
and glial cultures, and a similar effect was observed in puriﬁed
retinal neuronal cultures (data not shown). Mouse ADK sequence
is known to have potential phosphorylation sites for several
kinases, including ERK [42]. However, this same work showed that
ERK was not able to phosphorylate recombinant mouse ADK
in vitro. On the other hand, insulin has been shown to modulate
ADK expression in rat lymphocytes by a mechanism mediated by
MAPK cascade [11]. Our data indicate that the effect of MEKinhibitors on [3H]-adenosine uptake by retinal cultures was not
due to inhibition of ADK activity, since we have not detected any
signiﬁcant change in the amount of nucleotides formed after
adenosine uptake. This raises the possibility that ERK is directly
modulating transporter activity and not adenosine metabolism.
To our knowledge, this is the ﬁrst report demonstrating a role for
the MAP kinase pathway in the control of ENT activity. One report
shows that all-trans-retinoic acid-induced human CNT3 trafﬁcking
to the plasma membrane is mediated by a TGF-b1 and ERK 1/2-
dependent mechanism [43].
Huang et al. [30,31] performed a screening work to identify pos-
sible effects of different kinase inhibitors on nucleoside uptake by
human erythroleukemia K562 cell line, which is a cell line express-
ing NBTI-sensitive ENTs, and observed that inhibitors of receptor
tyrosine kinases, PKC, cyclin-dependent kinases and p38 MAPK
can affect nucleoside transport in a kinase-independent fashion.
It is interesting to stand out that the authors did not observe any
effect on uptake of the same MEK inhibitors used in the present
work, PD98059 or U0126. Moreover, U0124, an inactive analog of
U0126, had no effect on [3H]-adenosine uptake in our cultures,
strongly indicating that the effects of different MEK inhibitors on
[3H]-adenosine uptake are due to inhibition of the kinase itself,
and not to eventual unspeciﬁc effects directly on NTs.
In conclusion, this study showed that both adenosine metabolic
enzymes as well as ERKs are regulators of [3H]-adenosine uptake
probably through regulation of ENTs, but the mechanisms involved
remains to be clariﬁed. There is a great interest in studying the
mechanisms involved in the control of adenosine levels as adeno-
sine might be a neuroprotective agent in different pathological
conditions.
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